Redhill Biopharma
RDHL
C$2.04
Share price
-9.20%
Change (1 day)
-85.03%
Change (1 year)
Categories
Market capitalization of Redhill Biopharma (RDHL)
Market cap: C$4.67 Million
As of July 2025 Redhill Biopharma has a market cap of C$4.67 Million. This makes Redhill Biopharma the world's 10436th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Redhill Biopharma from 2013 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | C$4.67 M | -63.16% |
| 2024 | C$12.69 M | -66.67% |
| 2023 | C$38.09 M | 119.42% |
| 2022 | C$17.36 M | -89.92% |
| 2021 | C$0.17 B | -55.63% |
| 2020 | C$0.38 B | 38.89% |
| 2019 | C$0.27 B | 30.37% |
| 2018 | C$0.21 B | 56.01% |
| 2017 | C$0.13 B | -42.67% |
| 2016 | C$0.23 B | 5.58% |
| 2015 | C$0.22 B | 67.06% |
| 2014 | C$0.13 B | 68.06% |
| 2013 | C$80.89 M |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Redhill Biopharma was reported to be:
C$4.66 Million
C$4.67 Million
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | C$167.21 B | 3,574,927.99% | 🇫🇷 France |
 Merck MRK | C$285.68 B | 6,107,645.41% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$105.17 B | 2,248,410.18% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | C$2.22 B | 47,440.81% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | C$26.46 B | 565,743.68% | 🇮🇱 Israel |